BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn
FRANKLIN LAKES, N.J. and SANTA BARBARA, Calif., Aug. 4 /PRNewswire/ -- BD (Becton, Dickinson and Company) and Direct Relief International announced today the launch of a new nationwide program to help people with insulin-dependent diagnosed diabetes who have been affected by the current ...
Bedford Laboratories(TM) to Begin Shipping Ceftriaxone for Injection USP
BEDFORD, Ohio, July 16 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., announced FDA approval to begin shipping Ceftriaxone for Injection
USP. This product is AP rated and is equivalent to Rocephin(R) by Roche. Ceftriaxone is a semisynthetic, broad...
Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting
Three-year data show olanzapine LAI safety findings consistent with oral olanzapine except for injection-related events
INDIANAPOLIS, May 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company presented today data on the short- and long-term efficacy and safety of olanzapine long-acting injection...
Tigermed and Qiming Venture Grant Asset Injection to MacroStat
HANGZHOU, China, March 3 /PRNewswire-Asia/ --
Tigermed Consulting Co., Ltd, a leading Contract Research Organization
(CRO) in China, and Qiming Venture, a premier venture capital firm based in
Shanghai join hands to grant asset injection
to MacroStat, the unique CRO in
Data on VELCADE(R) (Bortezomib) for Injection Based Therapies to be Presented at the International Myeloma Workshop
CAMBRIDGE, Mass., Feb. 23 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced that 100 data presentations on VELCADE research will be featured at the Fifth International Myeloma Workshop (IMW) in Washington, D.C., February 26 - March 1, 2009. The 13 oral and 87 poster presenta...
Radiofrequency treatment better than ethanol injection for small liver tumors
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection
(PEI). These f...
Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
SAN DIEGO and INDIANAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY )
today announced that the U.S. Food and Drug Administration (FDA) is continuing
with its review of the regulatory application for use of BYETTA(R) (ex...
MEDRAD Builds on Success of P3T Cardiac CT Injection Software
WARRENDALE, Pa., Nov. 24 /PRNewswire/ -- Encouraged by successful results from use of its patented personalized patient protocol software P3T(TM) Cardiac, MEDRAD, Inc. is working on advancing the P3T family of products for clinical applications beyond Cardiac CT. MEDRAD will demonstrate some of th...
Study finds Canada's supervised injection facility cost-effective
Canada's only supervised injection
facility is extending lives and saving the health-care system millions of dollars, a new study shows.
In analyzing the cost-effectiveness of Vancouver-based Insite, a safe injection
facility in a downtown neighbourhood where about 5,000 injection
drug users l...
Diabetes Spectrum Reports a Study Assessing the i-port(R) Injection Port for Administration of Insulin
Device a "Viable Alternative" to Standard Injections - 69% of Patients
Report i-port(R) is Helpful in the Management of Their Diabetes
AUSTIN, Texas, Sept. 17 /PRNewswire/ -- In a clinical trial comparing
the i-port(R) (a small, disposable injection
port about the size of a
quarter) with stan...
FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
- New indication offers earlier treatment options for patients -
CAMBRIDGE, Mass. and OSAKA, Japan, June 20 /PRNewswire/ -- Millennium
Pharmaceuticals, The Takeda Oncology Company, and Takeda Pharmaceutical
Company Limited ("Takeda", TSE: 4502) today announced that the U.S. Food
and Drug A...
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
NANJING, China, May 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical
Group (NYSE: SCR ), a leading manufacturer and supplier of branded generic
pharmaceuticals and manufacturer of the patented anti-cancer biotech
product Endu in China, today announced that it has received approval from
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
-- Trial results of combination therapy VELCADE, melphalan and prednisone
reported a 32 percent complete remission rate with 85 percent of patients alive at three years --
CAMBRIDGE, Mass., March 13 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLN...
AANA Condemns Unsafe Injection Practices
Nurse anesthetists association entreats other healthcare professionals
to work together to solve infection control problems that put patients at
PARK RIDGE, Ill., March 6 /PRNewswire-USNewswire/ --- In a decisive
response to recent incidents in Nevada and New York in which patients we...
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
WOODCLIFF LAKE, N.J., March 2 /PRNewswire/ -- Eisai Corporation of
North America, its U.S. subsidiary, MGI PHARMA, INC., and Helsinn
Healthcare SA today announced that the U.S. Food and Drug Administration
(FDA) has approved Aloxi(R) (palonosetron hydrochloride) injection
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
INDIANAPOLIS, Feb. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company
(NYSE: LLY ) has received a not approvable letter from the U.S. Food and
Drug Administration for Zyprexa(R) long-acting injection
for the treatment and maintenance treatment of schizophrenia in adults, the
Bedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral Solution
BEDFORD, Ohio, Jan. 3 /PRNewswire/ -- Bedford Laboratories(TM), a
division of Ben Venue Laboratories Inc., announced the acquisition of
CAFCIT(R) (caffeine citrate) Injection
and CAFCIT(R) (caffeine citrate)
Oral Solution from Mead Johnson & Company. Bedford Laboratories is now the
Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
CAMBRIDGE, Mass., Dec. 21 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced the submission of a
supplemental new drug application (sNDA) with the U.S. Food and Drug
Administration (FDA) for VELCADE in the treatment of patients with
VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
ATLANTA, Dec. 10 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals,
Inc. (Nasdaq: MLNM ) today reported the presentation of results from a 482
patient, multi-center, randomized Phase III clinical trial, comparing
VELCADE and dexamethasone (VcD) to vincristine, adriamycin and
Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
- VELCADE, thalidomide and dexamethasone improved pre
- and post-stem cell transplantation results compared to thalidomide and dexamethasone -
ATLANTA, Dec. 9 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals,
Inc. (Nasdaq: MLNM ) reported the presenta...
Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy
- VELCADE based therapy achieved highly significant improvement across all efficacy endpoints including overall survival -
ATLANTA, Dec. 9 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals,
Inc. (Nasdaq: MLNM ) today announced the presentation of results from the
682 patient, ran...
New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
Data with investigational Taxotere(R) regimens in the management of breast cancer, across several disease stages, to be presented
BRIDGEWATER, N.J., Dec. 7 /PRNewswire-FirstCall/ -- Among the 62 oral
abstracts accepted for presentation at the 30th annual San Antonio Breast
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
- Underscores Benefit for Patients with Kidney Impairments - - Highlights Leading Role of VELCADE in Broad Range of Patients -
CAMBRIDGE, Mass., Oct. 15 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced that the U.S. Food and
Pill Equals Injection in Preventing Clots After Hip Replacement
Study found no difference between the two protective treatments
FRIDAY, Sept. 14 (HealthDay News) -- In a head-to-head trial, Swedish researchers found that a pill called dabigatran etexilate (DE) is just as effective as an injected drug, enoxaparin, in reducing the risk of blood clots after tot...
HCV and HBV spreading more slowly among injection drug users in San Francisco Injection
drug users are still at a very high risk of acquiring hepatitis C (HCV) and hepatitis B (HBV); however, needle-sharing is less common, and users do not become infected as quickly as they did in the past, according to a new study in the September issue of Hepatology, a journal published b...
Sagent Pharmaceuticals Announces Launch of First Two Oncolytic Products: Fludarabine Phosphate for Injection, USP and Epirubicin Hydrochloride Injection
SCHAUMBURG, Ill., Aug. 5 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched fludarabine phosphate for injection, USP and epirubicin hydrochloride injection. IMS data indicates the combined U.S. market...
Hospira Receives FDA Approval for Azithromycin for Injection
LAKE FOREST, Ill., June 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for a 500 mg vial of azithromycin for injection
in the ADD-Vantage(R) System. ...
Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection
Launch represents first available generic equivalent of Alkeran(R)
LAKE FOREST, Ill., and NEWTOWN, Pa., June 9 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Synerx Pharma, LLC, announced today the FDA approval and launch of Melphalan...
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
- First product approval from Sagent and Strides Arcolab Joint Venture -
SCHAUMBURG, Ill., March 26 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, ...
China Sky One Medical Inc. Gets SFDA Approval for Calcium Folinate Injection
HARBIN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a
leading fully integrated pharmaceutical company producing over-the-counter
drugs in the People's Republic of China ("PRC"), today announced that it
Bedford Laboratories(TM) to Begin Shipping Sumatriptan Succinate Injection
BEDFORD, Ohio, Feb. 25 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., today announced the launch of Sumatriptan Succinate Injection. This product is AP rated and is equivalent to Imitrex(R) by GlaxoSmithKline. Sumatriptan is a vascular headache suppressant ...
Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
BEDFORD, Ohio, Jan. 29 /PRNewswire-FirstCall/ -- Bedford Laboratories(TM),
a division of Ben Venue Laboratories, Inc., announced the launch of Irinotecan
HCl Injection. This product is AP rated and is equivalent to Camptosar(R).
Irinotecan is indicated for patients with metastatic carcinoma o...
FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) Injection
- Expands Therapy to Broader Patient Population -
LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP ), a global specialty pharmaceutical and medication delivery
company, announced today that the U.S. Food and Drug Administration (FDA)
approved a new indi...
Hot Flashes Reduced by Neck Injection
Treatment could help breast cancer patients and menopausal women, study finds
THURSDAY, May 15 (HealthDay News) -- An injection
of a local anesthetic into the nerves of the neck that regulate temperature could give breast cancer patients long-term relief from hot flashes and sleep depr...
Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
WOODCLIFF LAKE, N.J., May 7 /PRNewswire-FirstCall/ -- Par
Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it amended
its agreement with Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI ) for $20
million in cash to increase its share of profits from the generic versions
Hospira Launches Generic Irinotecan Injection
- Offers Unique Formulation of Important Cancer Medication -
LAKE FOREST, Ill., Feb. 27 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today
announced the launch of irinotecan hydrochloride injection
in the United
China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
-- The Approval Creates New Growth Opportunities for the Company
-- Potentially Denotes a Positive Sign Related to the SFDA Drug Approval Process
NEW YORK and HAIKOU, China, Jan. 29 /Xinhua-PRNewswire-FirstCall/ --
China Pharma Holdings, Inc. ("China Pharma...
Australian Patients Who Received Vitamin Injection Infected With Hepatitis C
Health authorities in the state of New South Wales in Australia are urging up to 2000 patients of a doctor in Sydney to test for hepatitis C and other blood-borne viruses . The move follows reports that five such persons had already contracted the highly infectious disease.
A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List
In an otherwise bleak healthcare scenario has emerged a heartening development.The World Health Organisation (WHO) has designated Paromomycin IM injection
manufactured by the US based Institute for OneWorld Health, a non-profit drug firm, for inclusion in its Model List for Essential Medicines. ...
Execution by Lethal Injection Questioned
The Lethal injection
to execute prisoners of death sentence is being questioned. A study by Plos medicine reveal that the lethal injection
causes intense pain//. It also upholds the study by the UK based Lancet in 2005.
is the foremost method used for execution in 34 states and...